<--- Back to Details
First PageDocument Content
Clinical research / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology / Drug safety / Investigational Device Exemption / New Drug Application / Federal Food /  Drug /  and Cosmetic Act / Medical device / Medicine / Food and Drug Administration / Health
Date: 2014-08-18 12:33:59
Clinical research
Pharmaceutical industry
Pharmaceutical sciences
Pharmacology
Drug safety
Investigational Device Exemption
New Drug Application
Federal Food
Drug
and Cosmetic Act
Medical device
Medicine
Food and Drug Administration
Health

E-ALERT | Food & Drug August 18, 2014 FDA ISSUES FINAL GUIDANCE ON "IN VITRO COMPANION DIAGNOSTIC DEVICES" On July 31, 2014, the Food and Drug Administration (FDA) released a final guidance entitled “In Vitro Companion

Add to Reading List

Source URL: www.cov.com

Download Document from Source Website

File Size: 117,76 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document